



Dynamic contrast-enhanced magnetic resonance
imaging of radiation therapy-induced microcirculation
changes in rectal cancer
Citation for published version (APA):
de Lussanet, Q. G., Backes, W. H., Griffioen, A. W., Padhani, A. R., Baeten, C. G., van Baardwijk, A. A.
W., Lambin, P., Beets, G. L., van Engelshoven, J. M. A., & Beets-Tan, R. G. H. (2005). Dynamic contrast-
enhanced magnetic resonance imaging of radiation therapy-induced microcirculation changes in rectal
cancer. International Journal of Radiation Oncology Biology Physics, 63(3), 1309-1315.
https://doi.org/10.1016/j.ijrobp.2005.04.052





Publisher's PDF, also known as Version of record
Document license:
Taverne
Please check the document version of this publication:
• A submitted manuscript is the version of the article upon submission and before peer-review. There can
be important differences between the submitted version and the official published version of record.
People interested in the research are advised to contact the author for the final version of the publication,
or visit the DOI to the publisher's website.
• The final author version and the galley proof are versions of the publication after peer review.




Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright
owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these
rights.
• Users may download and print one copy of any publication from the public portal for the purpose of private study or research.
• You may not further distribute the material or use it for any profit-making activity or commercial gain
• You may freely distribute the URL identifying the publication in the public portal.
If the publication is distributed under the terms of Article 25fa of the Dutch Copyright Act, indicated by the “Taverne” license above,
please follow below link for the End User Agreement:
www.umlib.nl/taverne-license
Take down policy
If you believe that this document breaches copyright please contact us at:
repository@maastrichtuniversity.nl
providing details and we will investigate your claim.














Int. J. Radiation Oncology Biol. Phys., Vol. 63, No. 5, pp. 1309–1315, 2005
Copyright © 2005 Elsevier Inc.
Printed in the USA. All rights reserved
0360-3016/05/$–see front matterdoi:10.1016/j.ijrobp.2005.04.052
LINICAL INVESTIGATION Colorectum
DYNAMIC CONTRAST-ENHANCED MAGNETIC RESONANCE IMAGING OF
RADIATION THERAPY-INDUCED MICROCIRCULATION CHANGES IN
RECTAL CANCER
QUIDO G. DE LUSSANET, M.D.*† WALTER H. BACKES, PH.D.,* ARJAN W. GRIFFIOEN, PH.D.,‡§
ANWAR R. PADHANI, M.B., B.S., COEN I. BAETEN, M.D.,‡§ ANGELA VAN BAARDWIJK, M.D.,§¶
PHILIPPE LAMBIN, M.D., PH.D.,§¶ GEERARD L. BEETS, M.D., PH.D.,#
JOS M. A. VAN ENGELSHOVEN, M.D., PH.D.,*† AND
REGINA G. H. BEETS-TAN, M.D., PH.D.*‡
Departments of *Radiology, ¶Radiation Therapy, Maastro Clinic, and #Surgical Oncology; †Cardiovascular Research Institute
Maastricht (CARIM) and §Research Institute for Growth and Development (GROW), Maastricht University, Maastricht,
The Netherlands; ‡Angiogenesis Laboratory, Department of Pathology and Internal Medicine, Maastricht University Hospital,
Maastricht, The Netherlands; Paul Strickland Scanner Centre, Mount Vernon Hospital, Northwood, Middlesex, UK
Purpose: Dynamic contrast-enhanced T1-weighted magnetic resonance imaging (DCE-MRI) allows noninvasive
evaluation of tumor microvasculature characteristics. This study evaluated radiation therapy related microvas-
cular changes in locally advanced rectal cancer by DCE-MRI and histology.
Methods and Materials: Dynamic contrast-enhanced-MRI was performed in 17 patients with primary rectal
cancer. Seven patients underwent 25 fractions of 1.8 Gy radiation therapy (RT) (long RT) before DCE-MRI and
10 did not. Of these 10, 3 patients underwent five fractions of 5 Gy RT (short RT) in the week before surgery.
The RT treated and nontreated groups were compared in terms of endothelial transfer coefficient (KPS, measured
by DCE-MRI), microvessel density (MVD) (scored by immunoreactivity to CD31 and CD34), and tumor cell and
endothelial cell proliferation (scored by immunoreactivity to Ki67).
Results: Tumor KPS was 77% (p  0.03) lower in the RT-treated group. Histogram analyses showed that RT
reduced both magnitude and intratumor heterogeneity of KPS (p  0.01). MVD was significantly lower (37%, p
 0.03) in tumors treated with long RT than in nonirradiated tumors, but this was not the case with short RT.
Endothelial cell proliferation was reduced with short RT (81%, p  0.02) just before surgery, but not with long
RT (p > 0.8). Tumor cell proliferation was reduced with both long (57%, p < 0.001) and short RT (52%, p 
0.002).
Conclusion: Dynamic contrast-enhanced-MRI–derived KPS values showed significant radiation therapy related
reductions in microvessel blood flow in locally advanced rectal cancer. These findings may be useful in evaluating
effects of radiation combination therapies (e.g., chemoradiation or RT combined with antiangiogenesis therapy),














ynamic contrast-enhanced magnetic resonance imaging
DCE-MRI) combined with pharmacokinetic modeling is a
romising noninvasive imaging technique for evaluating
umor microvasculature (1, 2). Although conventional MRI
llows qualitative tumor characterization (e.g., size and
ontrast agent uptake) (3–5), combining DCE-MRI with
eneral pharmacokinetic tracer-exchange analysis produces
hysiologic parameters that allow functional characteriza-
ion of changes in the tumor microvasculature (e.g., tumor
ngiogenesis) (6–8).
Reprint requests to: Quido G. de Lussanet, M.D., Department of
adiology, Maastricht University Hospital, P.O. Box 5800,
202AZ Maastricht, The Netherlands. Tel: (31) 43-387-6910 A
1309In rectal cancer patients, DCE-MRI–derived parameters
ave been shown to change early during the course of
adiation therapy (RT) (9) and to be related to the tumor
esponse to chemoradiation combination therapy (10, 11).
ew studies have looked at tumor microvascular character-
stics after RT alone, and none have good correlation with
istology. In animal tumor models, a DCE-MRI–derived
arameter for tumor blood flow, the endothelial transfer
oefficient (KPS), was shown to be related to immunohisto-
hemical microvessel density scores (MVD) (12, 13) and to
e useful for detecting effects of antivascular treatments
14–16). Although RT-related antivascular effects are a
-4910); Fax: ( 31) 43-387-6909; E-mail: qdlu@rdia.azm.nl


































































































1310 I. J. Radiation Oncology ● Biology ● Physics Volume 63, Number 5, 2005enerally accepted phenomenon (17), the extent to which
T affects the DCE-MRI–derived KPS in locally advanced
ectal cancer, for example, is unknown. Because RT is
ncreasingly being administered in combination with che-
otherapy or experimental therapies, including antivascular
gents (18), and DCE-MRI is becoming an accepted non-
nvasive surrogate marker for evaluating antivascular ef-
ects of these combination therapies, possible RT-related
ffects on DCE-MRI–derived parameters need to be as-
essed.
The purpose of this study was to evaluate the effects of
eoadjuvant RT in patients with locally advanced rectal
ancer by DCE-MRI and to correlate changes in DCE-MRI
ith immunohistochemical analysis of tumor vasculariza-
ion and proliferation of tumor cells and endothelial cells.
PATIENTS AND METHODS
atients and treatment
The ethical review board of our institute approved this study,
nd all patients gave written informed consent. DCE-MRI was
erformed in 17 patients (median age, 63  6 years [SD]) with
urable primary locally advanced rectal cancer. Twelve patients
ere male and 5 were female (3 in the long-RT group and 2 in the
roup without RT). Radiation therapy regimens were allocated by
he attending clinicians, who were not involved in the DCE-MRI
r histologic data acquisition and analysis. Seven patients under-
ent a long course of 25 fractions (25  1.8 Gy, total 45 Gy)
reoperative RT (indicated here as long RT) before DCE-MRI,
hereas 10 patients did not. Three of these 10 patients, however,
nderwent a short course of five fractions (5  5 Gy, total 25 Gy)
reoperative RT (short RT) in the week before surgery. Because
here is a potential difference in effect between short RT and long
T, the 3 patients with short RT were analyzed as a separate group
or the histologic analyses after surgery. Obviously, the time
etween the start of RT and surgery was significantly (p  0.001)
onger for long RT (SD, 46  16 days) than for short RT (8  2).
he average time between MRI and surgery was not significantly
ifferent (p  0.4) between the patients with long RT (SD, 18 
3 days), those without RT (25  20), or those with short RT (24
20).
RI
Dynamic contrast-enhanced magnetic resonance imaging was
erformed with a conventional clinical MRI scanner at 1.5 Tesla
Intera, Philips, Best, The Netherlands), with a five-element car-
iac phased array coil. DCE-MRI included six precontrast T1-
eighted measurements (3D fast-field echo, TR 8.0 ms, echo time
.9 ms, 10 axial slices [slice thickness, 8 mm], field-of-view 290 
90 mm, matrix 128  128) with different flip angles (FAs) (2°,
°, 10°, 15°, 25°, and 35°) to determine the T1 relaxation time in
he blood and tissue before contrast agent arrival, on a pixel-by-
ixel basis (19). This was followed by the dynamic contrast-
nhanced series using the same sequence but with an FA of 35°
nly (250 scans of 2.4 s), for a total duration of 10 min. Gado-
entetate dimeglumine (Schering AG, Berlin, Germany; 0.15
mol/kg body weight) was injected intravenously (3 mL/s) and
ushed with 15 mL saline (3 mL/s) at the start of the eighth
ynamic scan.RI data analysis
Magnetic resonance imaging data were analyzed using a general
inetic two-compartment exchange model as described, for exam-
le, by Daldrup et al. (6, 13). Briefly, local T1 relaxation rates of
he precontrast time-averaged images and contrast-enhanced im-
ge signal intensity time courses (Fig. 1) were used to determine
he concentrations of contrast medium in the blood plasma (com-
on femoral arteries), tumor, and gluteus maximus muscle. An
xperienced gastrointestinal radiologist defined the tumor volume
egion of interest on the T1-weighted images. Application of the
eneral kinetic model (6, 13) yielded the KPS, the reflux rate (k),
oth expressed as mL/min/100 cm3 of tissue, and the plasma
raction (fPV) values as mL/100 cm3 of tissue. Dividing KPS by k
ielded the volume fraction of the extravascular extracellular space
EES). Values of KPS, fPV, and EES in individual voxels were
ollected for tumor histogram analysis (20, 21) and to determine
he median tumor values and median tumor/muscle ratios. Intra-
umor heterogeneity was assessed by the 95th percentile tumor
alues.
The tumor perfusion index (PI) (mL/min/100 cm3 of tissue) was
lso calculated according to the method described by de Vries et
l. (11). PI is the maximum of the temporal derivative of the
emporal changes in T1-relaxation rate divided by the correspond-
ng T1-relaxation rate change early after contrast injection.
istology and immunohistochemistry
Serial sections (thickness 5 m) from the most invasive tumor
rea were used for immunohistochemical stainings to determine
VD, and endothelial cell and tumor cell proliferation was as-
essed by double staining with a mixture of Ki-67 antibody (rabbit
nti-human, Clone SP6, Laboratory Vision, Fremont, CA) and
ouse anti-human CD31 (Dako, Glostrup, Denmark) in combina-
ion with mouse QBEND-10 anti-CD34 (Monosan, Uden, Neth-
rlands). Ki-67 antibody was detected by biotin-labeled swine
nti-rabbit IgG (Dako), incubated with avidine-biotin complex
RP (Dako) and developed with diaminobenzidine (DAB, Sigma).
D31 and CD34 were detected by alkaline phosphatase labeled
oat anti-mouse IgG (Dako). The sections were mounted in imsol
Imsol-Mount, Klinipath, Duiven, The Netherlands).
ig. 1. Representative (i.e., median endothelial transfer coefficient)
ignal intensity time courses measured with dynamic contrast-
nhanced magnetic resonance imaging in a tumor without radia-
ion therapy (RT) (a) show that its increase in signal intensity
irectly after contrast injection is smaller but similar to the steep
ignal increase in the blood including the small recirculation peak.
onversely, in a tumor with long RT (b), the signal intensity
ncrease is slower and prolonged, unlike the blood signal, and the
ecline in tumor signal is substantially slower than in the tumor























1311DCE-MRI of radiation therapy effects in rectal cancer ● Q. G. DE LUSSANET et al.helial cell proliferation (CD31/CD34 and Ki67) were deter-
ined independently by two observers along a predefined line
rom the luminal side of the tumor to the deepest invasion, as the
otal number of vessels divided by the area (number of 0.22 mm2
ptic fields). The endothelial cell proliferation ratio was calculated
y dividing the number of proliferating endothelial cells by the
VD. The ratio of the number of Ki67 tumor cells and the total
umber of tumor cells in the predefined line was scored as 1
25%), 2 (25–75%), or 3 (75%). The total number of Ki-67
umor cells/mm2 was counted in three predefined Ki-67 hot spots
optic field, 0.22 mm2).
tatistical methods
Differences in histologic and immunohistochemical scores and
Fig. 2. (a) Axial T2-weighted images were used to locate the
coefficient (KPS) without radiation therapy (RT) (left) and with
the common femoral arteries directly after contrast injection on
gray scale–coded tumor KPS maps, which illustrate that KPS
histogram distribution plots for all tumors show that (b) KPS a
smaller intertumor variation) in tumors with long RT (black bar
extracellular space (EES) is just slightly increased in tumors w
*Indicates that the highest values (KPS 95.0, EES 63.3, anedian DCE-MRI parameters between the groups with and with- cut RT were compared using the two-sample (two-tailed) Student
test. The Pearson correlation coefficient (r) was calculated to
eveal a possible relationship between tumor PI and KPS values.
tatistical significance was inferred at the p  0.05 level.
RESULTS
CE-MRI findings
All patients underwent DCE-MRI without difficulties in
he imaging procedures.
A slower “leakage” of contrast medium into the tumor
as found (a difference of 77% [p  0.03]) in patients who
ad received RT, as assessed by the endothelial transfer
Shown here are tumors with the median endothelial transfer
RT (right); the top inserts illustrate the signal enhancement in
responding T1-weighted acquisition; the bottom inserts are the
er in magnitude and heterogeneity after long RT. Averaged
plasma fraction (fPV) are lower and less heterogeneous (i.e.,
in tumors without RT (white bars); whereas (d) extravascular












































































1312 I. J. Radiation Oncology ● Biology ● Physics Volume 63, Number 5, 2005nalysis of all tumor pixel KPS values yielded lower ranges
f KPS measured in tumors with RT than in tumors without
T (Fig. 2b). These lower ranges of tumor KPS values in
umors with RT were reflected by the lower 95th percentile
umor KPS values (p  0.02), and by the tumor:muscle ratio
p  0.03) (Table 1). In contradistinction, KPS in muscle
issue was slightly higher in tumors with RT than in tumors
ithout RT (NS, p  0.3) (median  SD, 8.1  8.1 after
T, and 4.6  2.8 without RT).
The significant correlation (r  0.74, p  0.001) that was
bserved between the tumor KPS and the perfusion index
PI) for all tumors combined reflects the overall similarity
etween these parameters. Unlike KPS, however, PI did not
how significant differences in relation to RT (p  0.5)
median PI  SD was 34  10 after RT, and 39  21
ithout RT).
Histogram analysis suggested lower fPV values in tumors
ith RT than in tumors without RT (Fig. 2c). However,
hese differences were not significant, either for median
umor fPV values (p  0.3) or for 95th percentile values (p
0.3) (Table 1). Because fPV values were very low (some-
imes approaching zero), the tumor:muscle fPV ratio did not
esult in realistic values and was therefore not calculated.
No significant (p  0.4) changes were observed in tumor
ES values. Tumor:muscle ratios were, however, about
wice as high (NS, p  0.1) in tumors with RT than in
umors without RT (Table 1, Fig. 2d).
istologic findings
Tumor cell proliferation was significantly lower (p 
.0006) in the tumors that were treated with long RT than in
hose not treated with RT; lower tumor cell proliferation
as also observed in the three tumors treated with short RT
p  0.02) (Fig. 3a).
The long RT regimen resulted in significantly (p  0.03)
ower MVD scores compared with the nonirradiated tumors
Fig. 3b), but the short RT regimen did not. Endothelial cell
roliferation ratios were significantly (p  0.05) lower after
he short RT regimen, which had been administered during
he week before surgery, as compared with nonirradiated






PS No RT 28.6  26.8 67.8  55.2 6.5  6.3
Long RT 6.5  2.4 15.4  4.1 1.5  1.0
PV No RT 2.3  2.0 1.8  1.7 —
Long RT 1.4  1.1 1.2  0.9 —
ES No RT 0.39  0.15 0.31  0.15 1.3  0.3
Long RT 0.43  0.11 0.35  0.13 2.1  1.3
Abbreviations: DCE  MRI/dynamic contrast-enhanced; KPS
endothelial transfer coefficient; fPV  plasma fraction; EES 
xtravascular extracellular space; RT  radiation therapy.umors, but not after the long RT (p  0.8), which had been fidministered in the course of several weeks before surgery
Fig. 3c).
DISCUSSION
The results of this study demonstrate significant RT-
elated microcirculation changes in locally advanced rectal
ancer, as assessed by DCE-MRI and histology.
The DCE-MRI derived KPS, measured using a low mo-
ecular-weight contrast agent, largely reflects tumor blood
ow, as well as the leakiness (i.e., microvessel permeability
urface area product) of the tumor microvessels (21, 22).
herefore, KPS was effective in showing effects of long RT
hat occur approximately 2–4 weeks after the initiation of
T (17).
Radiation Therapy damages all blood vessels, but specific
ffects depend on vessel size, location, and dose–time–
olume factors (17). Although acute effects of RT are
arked by increased microvascular permeability, related to
ndothelial cell damage and local inflammation, longer term
ffects are marked by decreased permeability, resulting
ig. 3. (a) The average number of Ki-67 tumor cells was signif-
cantly (*) higher in tumors without radiation therapy (RT) than
n tumors irradiated with long RT and short RT; (b) microvessel
ensity (MVD) was significantly (*) lower only after long RT
with respect to RT); (c) Ki-67 endothelial cell proliferation ratio
as lower only after short RT; (d) tumor cell proliferation is
arked by the brown, nuclear staining of tumor cells (to Ki67)
large diagonal arrows); the arrowheads depict tumor blood vessels
blue, staining of endothelial cells to CD31 and CD34); note the
rown staining of the typical elongated nucleus in an endothelial
ell (blue), suggesting angiogenic endothelial cell proliferation in
he tumor without RT (small horizontal arrow). Significant differ-
nces are indicated by *(p  0.02) and #(p  0.05). The magni-








































































































1313DCE-MRI of radiation therapy effects in rectal cancer ● Q. G. DE LUSSANET et al.rom basement membrane thickening and extracapillary fi-
rosis (17). Additional chronic effects of RT are the inhi-
ition of capillary sprouting and vascular remodeling (23),
educed MVD, endothelial cell destruction, and reduced
icrovessel functionality as a result of mural thrombi and
bliteration of the vessel lumen (17).
KPS is expected to be a more successful marker than other
CE-MRI derived markers, such as PI and area under the
ignal-intensity-time curve, because KPS represents a single
icrocirculatory parameter, whereas PI is a perfusion pa-
ameter that depends not only on KPS, but is also con-
ounded by (nonsignificant) changes in fPV and EES (22).
or example, our study showed a significant (77%) reduc-
ion in KPS, whereas PI was reduced by only 15% (which
as nonsignificant), despite the strong positive relationship
etween PI and KPS. De Vries et al. (9) reported increases
n PI during the first weeks of RT in rectal cancer, which
orresponds very well with reported acute effects of RT
17). The reported increases in PI were 25% at most, and the
bserved possible decline in PI after the final (fourth) week
f RT was not significant (9).
Presenting the true tumor KPS may be preferable over the
umor:muscle KPS ratio, because effects of RT in muscle are
ncertain. The gluteus maximus muscle, for example, is
everal centimeters posterior to the rectal tumor, but is still
t least partially within anteroposterior field of radiation.
lthough muscle is generally assumed to produce minimal
esponse to clinical irradiation, transient alterations and
arying degrees of atrophy and necrosis have been reported
or skeletal muscle after single doses of RT (24). High-dose
adical RT can cause persistent muscle edema, often visible
n MRI, probably reflecting long-term damage to muscle
icrocirculation. The increase in muscle KPS observed in
he current study did not affect the observed statistical
ifferences in tumor KPS in relation to therapy when ex-
ressed as a tumor:muscle ratio.
The DCE-MRI derived volume fraction of the EES
howed some increased intratumor variation after RT. Cell
estruction caused by radiation may have increased the
elative extracellular volume to which the contrast agent can
eak, hence increasing EES. In other parts of the tumor,
nfiltration of inflammatory cells and tissue fibrosis (25)
ay have decreased EES.
Immunohistochemistry results reflected the antitumor and
ntiangiogenesis effects of RT. Direct measures of antian-
iogenesis effects are reduced MVD and reduced Ki67
mmunoreactivity of endothelial cells. Our data show incon-
ruous effects between long and short RT, although it
hould be noted that the number of patients who underwent
hort RT was limited. Explanations why short RT yielded
ow endothelial cell proliferation without differences in
VD, whereas long RT yielded low MVD without differ-
nces in endothelial cell proliferation, as compared with
onirradiated tumors, might be related to the higher fraction
osage with short RT or the shorter time interval between
T and surgery with short RT, compared with long RT.
espite lower fraction dosages, long RT may have had short-term effects on endothelial cell proliferation, but en-
othelial cell proliferation may have recovered during the
ime interval between RT and surgery, especially because
he fraction dosages were lower (26). Because the time
etween the completion of RT and surgery was less than a
eek for short RT and several weeks for long RT, it is also
ossible that in the short RT patients, we were observing the
cute effects, such as endothelial cell damage with reduced
roliferation, whereas in the long RT patients, we were
bserving the long-term effects, including endothelial cell
estruction and MVD reduction (17).
A larger number of patients would have allowed an
valuation of possible relationships between, for example,
PS and MVD, as demonstrated in animal studies (12, 13).
atient inclusion was stopped because of changes in treat-
ent protocols at our hospital (27, 28). The large intertumor
nd intratumor variability of KPS values, particularly in the
onirradiated patient group, in combination with the limited
umber of included patients, hampered strong statistical
ignificance. Future studies should therefore use larger sam-
le sizes to compare patient groups with different treatment
egimes (e.g., short RT vs. long RT).
Similarly, colocalizing MRI and histologic parameters
ight be considered more desirable than our use of one
representative” (e.g., median) value for each parameter.
or example, colocalization between KPS and MVD has
een demonstrated in animal tumor models, in which the
n-plane resolution of MRI (0.5  0.5 mm) matched the
ptic field of view of the histologic sections; therefore,
istologic sections could be closely matched with the MRI
ections, and maximum tumor diameters were typically less
han 1 cm (14). However, one can imagine the sampling
rrors that may occur when attempting to colocalize MRI
nd histology in these large rectal tumors in patients, and the
patial resolution on MRI was substantially lower than that
btained in mice.
Microvessel density is commonly used as a surrogate
arker for the tumor microvasculature to validate DCE-
RI derived parameters. However, one important aspect to
ote is that MVD may not fully equate to the DCE-MRI
arameters, because MVD depends on the staining of en-
othelial cells in blood vessels and is thus a morphologic
arker, whereas DCE-MRI derived parameters depend on
icrocirculatory perfusion and are therefore functional
arkers.
The antitumor effect of RT was most evident in the
eduction of proliferating tumor cells as detected by Ki67
mmunoreactivity in tumor cells. This was observed after
oth long and short RT regimens, and is consistent with
arlier reports (29). Although tumor cell immunoreactiv-
ty for Ki67 is not a direct measure of angiogenesis in
ectal cancer, it might be postulated that RT-related re-
uctions in tumor cell proliferation reduce the production























1314 I. J. Radiation Oncology ● Biology ● Physics Volume 63, Number 5, 2005linical implications
Although conventional gadolinium-enhanced MR se-
uences have limited additional value for morphologic diag-
ostic assessment of rectal cancer (5), new gadolinium-en-
anced MR protocols, such as DCE-MRI, will complement
onventional imaging of tissue morphology by noninvasive
valuation of (tumor) tissue physiology. DCE-MRI was used
ere to show that radiation therapy alone significantly inhibits r
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